Evidence map›Paper›PMID 39607005›Full record

ArticleFuture oncology (London, England)2024

Effect of dual bronchodilators plus preoperative rehabilitation in operable LC & chronic obstructive pulmonary disease.

Rong Zhou, Yan Qin, Song Hu, Yangyang Xu, Chunlai Feng

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07543601 (Enhanced COPD Management in Suspected Lung Cancer Patients - Improving Outcomes Through Timely Intervention), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07543601 narecruitingnot on this mapstarted 2026, after this paper: background citation

Enhanced COPD Management in Suspected Lung Cancer Patients - Improving Outcomes Through Timely Intervention

TypeinterventionalSponsorDitte Krag-HansenRan2026 to 2027Enrolled280ConditionsCOPD (Chronic Obstructive Pulmonary Disease), Lung Cancer (Diagnosis), Lung Neoplasm Malignant, Lung CarcinomaArmsTailored COPD consultations
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rong ZhouDepartment of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Yan QinDepartment of Gastroenterology, Changzhou Maternal and Child Health Care Hospital, Changzhou, Jiangsu, China.
Song HuDepartment of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Yangyang XuDepartment of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.
Chunlai FengDepartment of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study analyzed the application of dual bronchodilators in patients with non-small cell lung cancer (NSCLC) & chronic obstructive pulmonary disease (COPD) during the perioperative period. RESEARCH DESIGN AND

methodsA total of 100 patients with moderate to severe COPD who underwent thoracoscopic lobectomy were divided into two groups. The patients in the observation group (group O) were treated with umeclidinium/vilanterol and conventional treatment (oxygen therapy, assisted expectoration, respiratory rehabilitation training) during the perioperative period. The patients in the control group (group C) received conventional treatment. Lung function, arterial blood gas values, quality of life, postoperative adverse reactions, days of postoperative chest tube placement and hospitalization were assessed.

resultsBefore surgery, group O presented higher FEV1, FVC, PEF and MVV, elevated PO

conclusionsPerioperative inhalation of umeclidinium/vilanterol can effectively protect arterial blood gas and respiratory function in patients with LC complicated with COPD.

Indexed as

Bronchodilator AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsPulmonary Disease, Chronic ObstructiveQuinuclidinesAgedBenzyl AlcoholsChlorobenzenesFemaleHumansMaleMiddle AgedPneumonectomyPreoperative CareQuality of LifeRespiratory Function TestsBenzyl AlcoholsBronchodilator AgentsChlorobenzenesGSK573719Quinuclidinesvilanterolarterial blood gas valueschronic obstructive pulmonary diseasedual bronchodilatorslung functionNon-small cell lung cancerperioperative periodquality of life

Identifiers

PMID39607005
PMCPMC11776851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.